Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization

被引:6
|
作者
Lu, Jun Ling [1 ]
Molnar, Miklos Z. [1 ,2 ]
Sumida, Keiichi [1 ,3 ,4 ]
Diskin, Charles D. [5 ]
Streja, Elan [6 ]
Siddiqui, Omer A. [1 ]
Kalantar-Zadeh, Kamyar [6 ]
Kovesdy, Csaba P. [1 ,7 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Div Nephrol, Memphis, TN 38163 USA
[2] Semmelweis Univ, Dept Transplantat & Surg, Budapest, Hungary
[3] Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan
[4] Univ Tsukuba, Fac Med, Dept Nephrol, Ibaraki, Japan
[5] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA
[6] Univ Calif Irvine, Med Ctr, Harold Simmons Ctr Chron Dis Res & Epidemiol, Div Nephrol & Hypertens, Orange, CA USA
[7] Memphis VA Med Ctr, Nephrol Sect, Memphis, TN 38104 USA
关键词
chronic kidney disease; end-stage renal disease; hospitalization; mortality; pre-ESRD laboratory testing; CHRONIC KIDNEY-DISEASE; PREDIALYSIS NEPHROLOGY CARE; GLOMERULAR-FILTRATION-RATE; SERUM POTASSIUM; OUTCOMES; MANAGEMENT; SURVIVAL; DIALYSIS; ANEMIA; INITIATION;
D O I
10.1093/ndt/gfx192
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Previous studies have demonstrated that early pre-end-stage renal disease (ESRD) nephrology care could improve postdialysis prognosis. However, less is known about the specific types of interventions responsible for the improved outcomes. We hypothesized that more frequent predialysis laboratory testing is associated with better postdialysis outcomes in incident ESRD patients. Methods. In all, 23 089 patients with available outpatient laboratory tests performed during the 2-year predialysis (i.e. prelude) period were identified from a total of 52 172 American veterans with chronic kidney disease (CKD) transitioning to dialysis between October 2007 and September 2011. The associations between the frequency of combined laboratory tests, including serum creatinine, serum potassium and hemoglobin (test trio), with postdialysis mortality and hospitalization were examined in multivariable adjusted Cox and logistic regression models. Results. When entering the 2-year prelude period, the mean age (Standard Deviation) of the patients was 66.2 (SD 11.3) years and the mean estimated glomerular filtration rate was 46.8 (SD 23.9) mL/min/1.73 m(2). In all, 14% of patients had the test trio performed less than twice in 24 months and 8.9% had the trio measured more often than every other month. Over a 2.5-year median postdialysis follow-up period, 15 303 (66.3%) patients died (mortality rate 260/1000 patient-years). The adjusted hazard ratio of all-cause mortality and adjusted odds ratio of the composite of hospitalization or death associated with lab testing done >12/24 months compared with 2-<= 4/24 months were 0.68 [95% confidence interval (CI) 0.65-0.73] and 0.70 (95% CI 0.62-0.79), respectively. Conclusions. More frequent laboratory testing in patients with advanced CKD is associated with better clinical outcomes after dialysis. Further examination in clinical trials is needed before the implementation of more frequent laboratory testing in clinical practice.
引用
收藏
页码:789 / 795
页数:7
相关论文
共 50 条
  • [21] End stage renal disease
    Jevtic, V
    EUROPEAN JOURNAL OF RADIOLOGY, 2003, 46 (02) : 83 - 84
  • [22] Pre end-stage renal disease care: Opportunities and challenges
    Mendelssohn, DC
    PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 (02): : 113 - 114
  • [23] MANAGEMENT OF PRE-END-STAGE CHRONIC RENAL-FAILURE
    EARLE, DP
    CARDIOVASCULAR MEDICINE, 1978, 3 (12): : 1257 - &
  • [24] Erythropoietin treatment of anemia in pre-end-stage renal disease patients by physician practice.
    Xue, JL
    Ebben, J
    St Peter, W
    Collins, AJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) : A35 - A35
  • [25] Hypertension and mortality in end stage renal disease.
    Schmidt, DW
    Stidley, CA
    Hunt, WC
    Zager, PG
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S169 - S170
  • [26] Cardiovascular mortality in end-stage renal disease
    Collins, AJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 163 - 167
  • [27] Rheumatoid Arthritis and Mortality in End Stage Renal Disease
    Paudyal, Sunita
    Waller, Jennifer L.
    Oliver, Alyce
    Le, Brian
    Zleik, Nour
    Nahman, N. Stanley
    Carbone, Laura
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 (02) : 48 - 53
  • [28] Depression and Mortality in End-Stage Renal Disease
    Halen, Nisha Ver
    Cukor, Daniel
    Constantiner, Melissa
    Kimmel, Paul L.
    CURRENT PSYCHIATRY REPORTS, 2012, 14 (01) : 36 - 44
  • [29] Depression and Mortality in End-Stage Renal Disease
    Nisha Ver Halen
    Daniel Cukor
    Melissa Constantiner
    Paul L. Kimmel
    Current Psychiatry Reports, 2012, 14 : 36 - 44
  • [30] End-Stage Renal Disease: Medical Management
    Wouk, Noah
    AMERICAN FAMILY PHYSICIAN, 2021, 104 (05) : 493 - 499